The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication
The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication is a paper indexed in ScholarIQ from OpenAlex.
How many citations does The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication have?
The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication has 54 citations in the OpenAlex counts ScholarIQ stores.
When was The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication published?
The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication has 2017 year in the ScholarIQ index.
What is the open-access status of The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication?
The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication has diamond oa status in the ScholarIQ index.
What is the DOI of The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication?
The DOI for The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication is on the source record.
What is the PMID of The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication?
The PMID for The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication is on the source record.
What is the OpenAlex record for The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication?
The OpenAlex for The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication is on the source record.